Private company

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. is a surgical and medical instruments and apparatus company.1 It is headquartered in Elk City, Idaho.1

Last updated Oct 20, 2026.

Overview

  • IndustrySurgical & Medical Instruments & Apparatus1
  • HeadquartersElk City, Idaho1
  • Business address701 Wild Rose Lane, Elk City, Id 835252
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

Dealers, Inc. to Therapeutic Solutions International, Inc., and acquired Splint Decisions, Inc., a California corporation.3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

62.9%Gross margin4
-2006.7%Operating margin4
-2191.9%Net margin4
-52.1%Revenue growth, 20234
-192.8%Return on equity4
-$1.1MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Cost of revenue4¢$36.8K
  • Research and development55¢$560.7K
  • Interest41¢$423.3K
  • Income tax0¢$2.2K

Out of $99.0K in revenue.4 The company lost money this year.

Financial statements

Revenue567894$99.0K in 2023+3372% since 2017
0$100.0K$200.0K$300.0K2017: $2.9K$2.9K20172018: $3.5K$3.5K2018+22%2019: $27.5K$27.5K2019+689%2020: $62.7K$62.7K2020+128%2021: $146.0K$146.0K2021+133%2022: $206.8K$206.8K2022+42%2023: $99.0K$99.0K2023−52%
Gross profit567894$62.2K in 2023+2968% since 2017
0$50.0K$100.0K$150.0K2017: $2.0K$2.0K20172018: $1.3K$1.3K2018−35%2019: $24.5K$24.5K2019+1745%2020: $49.9K$49.9K2020+104%2021: $103.4K$103.4K2021+107%2022: $127.3K$127.3K2022+23%2023: $62.2K$62.2K2023−51%
Operating income567894-$2.0M in 2023+125% since 2017
-$4.0M-$3.0M-$2.0M-$1.0M02017: -$884.3K-$884.3K20172018: -$1.2M-$1.2M2018+36%2019: -$1.0M-$1.0M2019−13%2020: -$1.8M-$1.8M2020+77%2021: -$2.3M-$2.3M2021+25%2022: -$3.3M-$3.3M2022+42%2023: -$2.0M-$2.0M2023−39%
Net income567894-$2.2M in 2023+118% since 2017
-$4.0M-$3.0M-$2.0M-$1.0M02017: -$995.5K-$995.5K20172018: -$1.9M-$1.9M2018+88%2019: -$1.7M-$1.7M2019−9%2020: -$2.2M-$2.2M2020+30%2021: -$3.0M-$3.0M2021+35%2022: -$3.8M-$3.8M2022+29%2023: -$2.2M-$2.2M2023−43%
Fiscal year2017201820192020202120222023
Revenue$2.9K5$3.5K6$27.5K7$62.7K8$146.0K9$206.8K4$99.0K4
Cost of revenue$82313$12.8K8$42.5K9$79.4K4$36.8K4
Gross profit$2.0K5$1.3K6$24.5K7$49.9K8$103.4K9$127.3K4$62.2K4
Research and development$562.0K8$794.8K9$1.5M4$560.7K4
Operating expenses$2.4M9$3.4M4$2.0M4
Operating income-$884.3K5-$1.2M6-$1.0M7-$1.8M8-$2.3M9-$3.3M4-$2.0M4
Interest$53.4K5$241.8K6$350.7K7$302.5K8$611.8K9$646.1K4$423.3K4
Income before tax-$3.0M9-$3.9M4-$2.2M4
Income tax$8009$1.6K4$2.2K4
Net income-$995.5K5-$1.9M6-$1.7M7-$2.2M8-$3.0M9-$3.8M4-$2.2M4
Earnings per share$0.009$0.004$0.004
Earnings per share (diluted)$0.004$0.004
Shares (weighted, basic)2.3B shares92.5B shares43.2B shares4
Shares (weighted, diluted)2.5B shares43.2B shares4

Compare THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. with another company

Corporate structure

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

  • Jadi Cell, LLC Filed SC 13G/A on THERAPEUTIC SOLUTIONS INTERNATIONAL, INC., latest Feb 15, 2023 (2 filings since Apr 20, 2022)
  • THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Elk City, Idaho

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$413.5K4 Dec 31, 2023$301.4K4 Dec 31, 2022+37.2%
Accumulated depreciation$39.2K4 Dec 31, 2023$28.3K4 Dec 31, 2022+38.5%
Property and equipment, net$374.4K4 Dec 31, 2023$273.1K4 Dec 31, 2022+37.1%
Operating-lease assets (leased space)$125.6K4 Dec 31, 2023$8.6K4 Dec 31, 2022+1357.9%

Real estate and locations

ItemLatestA year beforeChange
Area of land1,700 sq ft4 Mar 22, 20231,700 sq ft8 Dec 31, 20210%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$27.8K4 Dec 31, 2023$18.4K4 Dec 31, 2022+50.9%

Intangibles and goodwill

ItemLatestA year beforeChange
Finite-lived intangibles, gross$3.3M4 Dec 31, 2023$3.3M4 Dec 31, 20220%
Accumulated amortization$559.1K4 Dec 31, 2023$258.2K4 Dec 31, 2022+116.6%
Finite-lived intangibles, net$2.7M4 Dec 31, 2023$3.0M4 Dec 31, 2022−10.0%

Inventory

ItemLatestA year beforeChange
Inventory, total$22.6K4 Dec 31, 2023$42.4K4 Dec 31, 2022−46.8%

Leadership

Who has led THERAPEUTIC SOLUTIONS INTERNATIONAL, INC., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Timothy G. Dixon2011–2024

Chair

  1. Timothy G. Dixon2011–2012

President

  1. Timothy G. Dixon2011–2024

Chief financial officer

  1. Gerry B. Berg2011–2019
201520202025
Board members and other officers (6)

Former names

  • Friendly Auto Dealers, Inc.Nov 21, 2007 to Mar 18, 20112

Timeline

  1. Apr 24, 20258-K Other events22
  2. Feb 28, 20258-K Other events23
  3. Feb 18, 20258-K Other events24
  4. Jan 10, 20258-K Bylaws or fiscal year changed; Shareholder vote25
  5. Nov 26, 20248-K Other events26
  6. Jul 31, 20248-K Other events27
  7. Jul 1, 20248-K Other events28
  8. May 31, 20248-K Entered a material agreement; Other events29
  9. May 31, 20248-K Entered a material agreement; Other events30
  10. May 6, 20248-K Other events31
  11. Feb 21, 20248-K Bylaws or fiscal year changed; Shareholder vote32
  12. Feb 20, 20248-K Bylaws or fiscal year changed33
  13. Nov 28, 2011New chief executive Timothy G. Dixon becomes CEO14

Filings

113 filings to the SEC since October 2021: 3 annual reports, 10 quarterly reports, 30 major events, 31 insider forms, 2 large holders, 37 other. The latest 20:

  1. May 16, 202515-12G EDGAR
  2. May 6, 202525 EDGAR
  3. Apr 24, 20258-K EDGAR
  4. Apr 2, 2025NT 10-K EDGAR
  5. Feb 28, 20258-K EDGAR
  6. Feb 18, 20258-K EDGAR
  7. Jan 10, 20258-K EDGAR
  8. Nov 26, 20248-K EDGAR
  9. Nov 20, 202410-Q EDGAR
  10. Nov 14, 2024NT 10-Q EDGAR
  11. Oct 2, 20244 EDGAR
  12. Oct 2, 20244 EDGAR
  13. Aug 19, 202410-Q EDGAR
  14. Aug 15, 2024NT 10-Q EDGAR
  15. Jul 31, 20248-K EDGAR
  16. Jul 15, 20244 EDGAR
  17. Jul 12, 20244 EDGAR
  18. Jul 12, 20244 EDGAR
  19. Jul 9, 20244 EDGAR
  20. Jul 9, 20244 EDGAR

The 113 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARTHERAPEUTIC SOLUTIONS INTERNATIONAL, INC.1
  • CIK0001419051
  • Employer ID (EIN)45-12264651
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Fiscal year endsDecember 311
  • Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address701 Wild Rose Lane, Elk City, ID 835251
  • Phone(760) 295-72081
  • Shares outstanding5,122,705,536 as of Nov 20, 202412
  • Public float$6.6M as of Jun 30, 20234
  • On EDGAR sinceNov 21, 20071
  • Filings398 in all: 8-K (94), 4 (80), 10-Q (51), NT 10-Q (22), 10-K (17), 10-Q/A (16), CORRESP (16), UPLOAD (15)1
    All 37 form types

    NT 10-K (11), S-1/A (7), SC 13G (7), 8-K/A (6), 10-K/A (5), 3 (5), EFFECT (5), POS AM (5), D (4), RW (3), S-1 (3), S-8 (3), SC 13D (3), SC 13D/A (3), 4/A (2), PRE 14C (2), 15-12G (1), 25 (1), 424A (1), 5 (1), 8-A12G (1), DEF 14A (1), DEF 14C (1), PRE 14A (1), PRER14C (1), S-3 (1), S-8 POS (1), SB-2 (1), SC 13G/A (1)

  • Latest filingsAnnual report (10-K) Apr 17, 2024
    Quarterly report (10-Q) Nov 20, 2024
    Proxy statement (DEF 14A) Sep 24, 2012
    Latest 8-K (8-K) Apr 24, 2025

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
    SEC EDGAROther events
  23. 23
    SEC EDGAROther events
  24. 24
    SEC EDGAROther events
  25. 25
  26. 26
    SEC EDGAROther events
  27. 27
    SEC EDGAROther events
  28. 28
    SEC EDGAROther events
  29. 29
  30. 30
  31. 31
    SEC EDGAROther events
  32. 32
  33. 33
  34. 34